Your Cart
Your cart is empty

Looks like you haven't added any test / checkup to your cart

Add Test / Checkup
User Sign In Health checkup offers
Lab Test

Cyfra 21-1 (Lung Cancer Marker) Test

Cyfra 21-1 is a tumor marker that is used in the monitoring and management of non-small cell lung cancer (NSCLC). It is a fragment of cytokeratin 19, a protein found in epithelial cells. In healthy individuals, Cyfra 21-1 levels are usually low. However, in certain conditions, including lung cancer, levels of Cyfra 21-1 may be elevated. This test measures the levels of Cyfra 21-1 in the blood


It is important to note that Cyfra 21-1 is not a definitive diagnostic tool for lung cancer but is rather used in conjunction with other tests and clinical evaluations. It can provide valuable information on the stage of the disease, efficacy of treatment, and monitoring for recurrence after treatment.

  • Profile Name: Cyfra 21-1 (Lung Cancer Marker) Test
  • Sample Type: Blood
  • Preparations Required: No special preparation is needed for this test.
  • Report Time: 4 days

What is the Cyfra 21-1 test used for?

The Cyfra 21-1 test is primarily used to monitor treatment response and check for recurrence in patients with non-small cell lung cancer.

How is the Cyfra 21-1 test performed?

A blood sample is drawn from a vein in your arm. The blood is then sent to a laboratory to measure the levels of Cyfra 21-1.

Home Sample Collection Process

1
Book your convenient slot
Book your convenient slot
2
Sample Collection by Phlebotomist
Sample Collection by Phlebotomist
3
Reporting of the sample at lab
Reporting of the sample at lab
4
Download Reports
Download Reports
Frequently Asked Questions

No, fasting is not required for the Cyfra 21-1 test.

Monitoring Cyfra 21-1 levels is important in evaluating how well a patient with non-small cell lung cancer is responding to treatment, and for early detection of disease recurrence.

Your doctor will recommend the Cyfra 21-1 test if you have been diagnosed with non-small cell lung cancer and it's necessary to monitor the progression or response to treatment.

Normal values for Cyfra 21-1 are typically less than 3.3 ng/mL, but this can vary depending on the laboratory that analyzes the test.

High levels of Cyfra 21-1 may indicate the presence or progression of non-small cell lung cancer. However, elevated levels can sometimes be due to other factors or conditions.

Yes, smoking, inflammation, and some benign diseases can affect Cyfra 21-1 levels.

You should consult an oncologist if your Cyfra 21-1 levels are abnormal.

Quitting smoking and maintaining a healthy lifestyle may have a positive effect on your overall health but it's unclear how directly it affects Cyfra 21-1 levels.

No, Cyfra 21-1 is not used as a standalone diagnostic tool for lung cancer. It is used alongside other tests and evaluations.

Yes, higher levels of Cyfra 21-1 are often associated with more advanced stages of non-small cell lung cancer.

The frequency of the Cyfra 21-1 test depends on various factors such as the stage of cancer, the type of treatment, and your doctor’s recommendations.

There are no specific precautions. However, it’s always good to inform your doctor of any medications or supplements you are taking.

No, the Cyfra 21-1 test cannot be done at home. It requires a blood sample to be taken by a healthcare professional and analyzed in a laboratory.

Cyfra 21-1 is an important biomarker for patients with non-small cell lung cancer. It can help in monitoring the disease and evaluating the effectiveness of treatment. It is not a definitive diagnostic tool and should be used as part of a comprehensive approach to managing lung cancer. Regular consultations with your doctor are crucial for proper monitoring and management of your condition.

CYFRA (CA) 21-1, SERUM
₹ 4000
Schedule Test in Your Available Time
Locations Near You in Hyderabad
  • 4KM from Madhapur
  • 3KM from Banjara Hills
  • 1.9KM from Yusufguda
  • 3KM from Madhura Nagar
  • 5KM from Shaikpet